Lista de obras -

AE4 is a DIDS-sensitive Cl(-)/HCO(-)(3) exchanger in the basolateral membrane of the renal CCD and the SMG duct

scientific journal article

Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy

artículo científico publicado en 2013

An atypical case of acute kidney injury: Hemolytic uremic syndrome (HUS).

artículo científico publicado en 2015

An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome

artículo científico publicado en 2014

An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry

artículo científico publicado en 2016

An international consensus approach to the management of atypical hemolytic uremic syndrome in children

artículo científico publicado en 2015

Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles

artículo científico publicado en 2009

C3 deposition glomerulopathy due to a functional factor H defect

artículo científico publicado en 2008

CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).

artículo científico publicado en 2015

Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome

artículo científico publicado en 2018

Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative

artículo científico publicado en 2012

Cochrane in context: pharmacological interventions for hypertension in children

artículo científico publicado en 2014

Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy

artículo científico publicado en 2013

DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome

artículo científico publicado en 2010

Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome

artículo científico publicado en 2007

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy

artículo científico publicado en 2011

Eculizumab and Refractory Membranoproliferative Glomerulonephritis

artículo científico publicado en 2012

Eculizumab hepatotoxicity in pediatric aHUS.

artículo científico publicado en 2014

Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome

artículo científico publicado en 2016

Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

artículo científico publicado en 2013

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies

artículo científico publicado en 2015

Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome

artículo científico publicado en 2016

FAT1 mutations cause a glomerulotubular nephropathy

artículo científico publicado en 2016

Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions

artículo científico publicado en 2005

Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency

artículo científico publicado en 2007

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

artículo científico publicado en 2008

HED

scholarly article

Hemolytic uremic syndrome caused by Bordetella pertussis infection

artículo científico publicado en 2010

Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis

artículo científico publicado en 2009

Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis

artículo científico publicado en 2009

MPGN II--genetically determined by defective complement regulation?

artículo científico publicado en 2007

Monitoring and modeling treatment of atypical hemolytic uremic syndrome

artículo científico publicado en 2012

Osteopontin mediates Citrobacter rodentium-induced colonic epithelial cell hyperplasia and attaching-effacing lesions

artículo científico publicado en 2010

Pandemic H1N1 influenza A infection and (atypical) HUS--more than just another trigger?

artículo científico publicado en 2010

Pathogenesis and treatment of ANCA-associated vasculitis-a role for complement.

artículo científico publicado en 2016

Pharmacological interventions for essential hypertension in children

artículo científico publicado en 2009

Pharmacological interventions for hypertension in children

artículo científico publicado en 2014

Pharmacological interventions for hypertension in children.

artículo científico publicado en 2014

Platelet-associated complement factor H in healthy persons and patients with atypical HUS.

artículo científico publicado en 2009

Podocytes Produce and Secrete Functional Complement C3 and Complement Factor H

scientific article published on 14 August 2020

Primary Human Derived Blood Outgrowth Endothelial Cells: An Appropriate In Vitro Model to Study Shiga Toxin Mediated Damage of Endothelial Cells

artículo científico publicado en 2020

Primary antiphospholipid syndrome presenting as renal vein thrombosis and membranous nephropathy ⬇️

artículo científico publicado el 23 de marzo de 2011

Severe atypical HUS caused by CFH S1191L--case presentation and review of treatment options

artículo científico publicado en 2009

Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches

artículo científico publicado en 2014

Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

artículo científico publicado en 2005

Successful treatment of DEAP-HUS with eculizumab

artículo científico publicado en 2013

The alternative pathway of complement and the thrombotic microangiopathies

artículo científico publicado en 2016

The global aHUS registry: methodology and initial patient characteristics

artículo científico publicado en 2015

The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome

artículo científico publicado en 2013

The role of defective complement control in hemolytic uremic syndrome

artículo científico publicado en 2006

Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).

artículo científico publicado en 2004

aHUS caused by complement dysregulation: new therapies on the horizon

artículo científico publicado en 2010

Lista de obras de

AE4 is a DIDS-sensitive Cl(-)/HCO(-)(3) exchanger in the basolateral membrane of the renal CCD and the SMG duct

Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy

An atypical case of acute kidney injury: Hemolytic uremic syndrome (HUS).

An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome

An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry

An international consensus approach to the management of atypical hemolytic uremic syndrome in children

Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles

C3 deposition glomerulopathy due to a functional factor H defect

CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).

Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome

Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative

Cochrane in context: pharmacological interventions for hypertension in children

Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy

DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome

Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy

Eculizumab and Refractory Membranoproliferative Glomerulonephritis

Eculizumab hepatotoxicity in pediatric aHUS.

Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome

Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies

Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome

FAT1 mutations cause a glomerulotubular nephropathy

Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions

Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

HED

Hemolytic uremic syndrome caused by Bordetella pertussis infection

Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis

Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis

MPGN II--genetically determined by defective complement regulation?

Monitoring and modeling treatment of atypical hemolytic uremic syndrome

Osteopontin mediates Citrobacter rodentium-induced colonic epithelial cell hyperplasia and attaching-effacing lesions

Pandemic H1N1 influenza A infection and (atypical) HUS--more than just another trigger?

Pathogenesis and treatment of ANCA-associated vasculitis-a role for complement.

Pharmacological interventions for essential hypertension in children

Pharmacological interventions for hypertension in children

Pharmacological interventions for hypertension in children.

Platelet-associated complement factor H in healthy persons and patients with atypical HUS.

Podocytes Produce and Secrete Functional Complement C3 and Complement Factor H

Primary Human Derived Blood Outgrowth Endothelial Cells: An Appropriate In Vitro Model to Study Shiga Toxin Mediated Damage of Endothelial Cells

Primary antiphospholipid syndrome presenting as renal vein thrombosis and membranous nephropathy ⬇️

Severe atypical HUS caused by CFH S1191L--case presentation and review of treatment options

Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches

Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

Successful treatment of DEAP-HUS with eculizumab

The alternative pathway of complement and the thrombotic microangiopathies

The global aHUS registry: methodology and initial patient characteristics

The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome

The role of defective complement control in hemolytic uremic syndrome

Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).

aHUS caused by complement dysregulation: new therapies on the horizon